Drug intelligence / Profile preview

simethicone + N-acetyl cysteine

Development stage
Unknown
Lead developer
GSK
Modality
Small Molecules
Administration
Oral
01

Overview

Simethicone + N-acetyl cysteine is an oral combination of two agents used primarily as premedication to improve mucosal visibility during upper gastrointestinal endoscopy (esophagogastroduodenoscopy, EGD). Simethicone acts as an anti-foaming agent by reducing surface tension of gas bubbles in the GI tract, thereby dispersing and preventing the formation of foam. N-acetyl cysteine (NAC) is a mucolytic that breaks down mucus by cleaving disulfide bonds in mucoproteins. The combination has been shown in multiple randomized controlled trials and meta-analyses to significantly improve mucosal visualization compared to placebo or either agent alone, reduce procedure time, and decrease the need for flushing during EGD. No significant adverse effects have been reported with this premedication regimen[1][2][3][4][5][6][7].

Brand names
Espumisan + ACC long
Other names
simethicone and N-acetylcysteinesimethicone plus NACS + NAC
02

Targets

MUC (Mucin family)

Beyond the preview

Go deeper on simethicone + N-acetyl cysteine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on simethicone + N-acetyl cysteine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call